Recent Buy // DIS

I purchased 10 shares of The Walt Disney Company (DIS) on 3/21/2018 for $102.00 per share.

Valuation

• The P/E ratio at time of purchase was 14.2, which is lower than DIS’s 5 year average of 20.2.
• Morningstar valuation: $130, rated a 4-star “BUY”

Conclusion

The Walt Disney Company is still an attractively valued high-quality stock. They have a business model that is easy to understand, are well-respected as leaders in their industry, have a great balance sheet and have plenty of room to grow the dividend rate. I’m looking forward to more opportunities to add to my position here!

This purchase will add $16.80 to my annual dividend income based on the current $0.84 semi-annual dividend.

Full Disclosure: Long DIS

Thanks for reading.

Images: Death to the Stock Photo with graphics added by One Woman’s Worth.

Recent Buy // PEP

I purchased 10 shares of Pepsico, Inc. (PEP) on 3/21/2018 for $109.00 per share.

 

Quantitative

• EPS is 3.38 and has increased by an average of 5% over the last 10 years.
• Current dividend yield is 3.07% and pays a dividend of $3.22 per share. PEP has been increasing dividends for 45 years and the payout ratio is currently 64.3%.
• Debt/Equity ratio is currently at 2.93.

Valuation

• The P/E ratio is currently 31.8 which, while slightly above its 5 yr average, is reasonable.
• Morningstar Valuation: $123, 4-star BUY

Conclusion

There are risks associated with PEP. As consumers become more and more health conscious, companies like Pepsico, Coca-Cola, McDonald’s, etc. need to innovate and not rely so heavily on their non-healthy products. PepsiCo has been accomplishing this by selling bottled waters, teas and juices. They also have diversity in the food segment with healthier options like rice cakes, oatmeal and chewy granola bars. The brand recognition coupled with the diverse products in pretty much any country in the world means this company deserves a core spot in my dividend portfolio.

This purchase adds $32.20 to my annual dividend based on the current $0.80 quarterly dividend.

Full disclosure: Long PEP

What do you think of PEP? Think there’s more opportunities for growth in this mammoth company?

Thanks for reading.

Images: Death to the Stock Photo with graphics added by One Woman’s Worth.

Recent Buy // AMGN

Hey there!

I’m back with another recent buy; however, this time I am repurchasing a company that I have purchased in the past. When you believe in a company in the long term, you should be able to continue to pick up more shares.

This is how I feel about AMGN.

I purchased 7 shares of Amgen, Inc. (AMGN) on 1/08/2018 for $179.90 per share.

Valuation

• The P/E ratio at time of is 16.35. This is slightly lower than the 5 year average of 18.5 and much lower than the S&P 500 average of 24.
• Morningstar valuation: $198, rated a 3 star “BUY”

Conclusion

Amgen,Inc. remains an attractive company for me to continue to invest in. Back in June 2016, when I first initiated a position in this company, I believed the company to be financially sound. So when given the opportunity to pick up more shares at a cheaper price, I jumped at the opportunity.

This additional purchase of AMGN adds an additional $36.96 to my annual dividend income, based on the current $1.32 quarterly dividend.

Full Disclosure: Long AMGN

Thanks for reading.

Images: Death to the Stock Photo with graphics added by One Woman’s Worth. 

Recent Buy // INTC

I purchased 22 shares of Intel Corp (INTC) on 10/27/2017 for $43.35 per share.

Intel Corp is one of the world’s largest chipmakers. Intel supplies processors for computer system manufactures such as Apple, Lenovo, HP, and Dell. Intel also manufactures motherboard chipsets, network interface controllers and integrated circuits, flash memory, graphics chips, embedded processors and other devices related to communications and computing.

Valuation

• The P/E at time of purchase was 15.7, which is slightly higher than INTC’s 5 year average of 13.4.
• Morningstar valuation: $36, rated a 2 star “BUY”

Recent Buy // MSFT

I purchased 14 shares of Microsoft Corp (MSFT) on 10/27/2017 for $85.72 per share.

Microsoft Corp is a technology company that develops, manufactures, licenses, supports and sells computer software, consumer electronics, personal computers, and services. Its business is organized into three segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing.

Valuation

• The P/E at time of purchase was 29.4, which is higher than MSFT’s 5 year average of 20.5 but lower than the industry average of 29.6.
• Morningstar valuation: $89, rated a 3 star “BUY”

Recent Buy // DIS

 

Hey there! Wow – it has been over a year since my last recent buy . In my opinion, the market is very much overvalued and most of my core positions are currently selling for a premium. This has made following my investing strategy of buying quality blue chip companies at or below their fair value a challenge. However, there are still some companies that are fairly valued – it just takes a little digging to find them!

I purchased 11 shares of The Walt Disney Company (DIS) on 10/13/2017 for $97.59 per share.

Disney has continued to come under scrutiny over the past few months over cord cutters and loss of revenue for ESPN. Since I last analyzed this company , Disney has decided against renewing licensing with Netflix and will eventually migrate all content onto their own streaming service. This has spooked investors but I believe this positions Disney well for the long-term.

Valuation

• The P/E ratio at time of purchase was 17.4, which is lower than DIS’s 5 year average of 19.6.
• Morningstar valuation: $130, rated a 4 star “BUY”

Conclusion

The Walt Disney Company is still an attractively valued high-quality stock. They have a business model that is easy to understand, are well-respected as leaders in their industry, have a great balance sheet and have plenty of room to grow the dividend rate. I’m looking forward to more opportunities to add to my position here!

This purchase will add $17.16 to my annual dividend income based on the current $0.78 semi-annual dividend.

Full Disclosure: Long DIS

Thanks for reading.

Images: Death to the Stock Photo with graphics added by One Woman’s Worth.

Recent Buy // AMGN

Hi Friends – Long time, no speak!

This summer has been a busy one. Especially for Mr. Market. There have been so many swings caused from anything as small as a small comment made by a US Presidential candidate to something as big as one of Europe’s largest economies deciding to leave the EU (#brexit). So, to say it’s been hard to time the market, is putting things mildly. However, as I mentioned many times before, time in the market is much more important than timing the market; which means when I have the money in hand and I find a compelling buy, I should pull the trigger. Which is exactly how I came to own this next buy.

I purchased 8 shares of Amgen, Inc. (AMGN) on 6/16/2016 for $150.84 per share.

Overview

Amgen, Inc. is the worlds largest independent biotechnology company that works in discovering, developing, manufacturing & delivering human therapeutics worldwide. Their principal products include Nuelesta/Neupogen which are used to prevent infections in patients undergoing cancer chemotherapy; Enbrel, used in the treatment of rheumatoid arthritis and other autoimmune diseases; and Epogen, used to treat anemia.

AMGN makes money by selling these medicines/treatments to treat diseases/life threatening illnesses. Since they hold patents to prevent other healthcare competitors from creating generic brand options, they not only have 100% market share but they also have a multi-year head start before competitors can come in and start developing their own versions of the medicines. Their customers are typically patients through pharmaceutical wholesale distributors, physicians (in clinics, dialysis centers, hospitals and pharmacies), and direct consumers.

Quantitative

• Revenue grew by approximately 10% over the last 5 years.
• EPS is 9.06 and has increased by 24.6% over the last 5 years.
• Dividend yield at time of purchase was 2.65% and AMGN pays a dividend of $4 per share. AMGN has been increasing dividends for 6 years and the payout ratio is currently 35.6%.
• Debt/Equity ratio: 1.04

Risks

As a biotechnology firm, Amgen is not without its risks. While they do hold multiyear patents that prevent other companies from competing in the same space, there are many other macro risks that affect Amgen; particularly in the US. Drug pricing issues, uncertainty about health care policies with the next US president and an overall lack of investor confidence in the industry present risks that one should be cognizant of when evaluating this company.

Valuation

• The P/E at the time of purchase was 16.1 which is lower than AMGN 5 year average of 17.8.
• Morningstar valuation (at time of purchase): $153, rated a 5 star “BUY”
• S&P Capital IQ valuation (at time of purchase): $171.20, rated a 4 star “BUY”

Conclusion

Amgen overall is an attractively valued company. Fortunately/Unfortunately, there has been a run up in the stock price (price is $170.68 per share at the time this post was published). However, I do feel that this is a still a great entry price for someone to initiate a new position in this company. In the biotech industry, AMGN is regarded as a leader and is highly respected. With a good balance sheet, low dividend payout ratio and attractive entry price, I am happy with my latest purchase and will look for more opportunities to acquire more.

This purchase adds $32 to my annual dividend income based on the current $1.00 quarterly dividend.

Full disclosure: Long AMGN

Thanks for reading.

Images: Death to the Stock Photo with graphics added by One Woman’s Worth.

 

Recent Buy // SBUX

Hi friends! I’m back at it again with another purchase – but with a stock that I’ve already vetted and purchased before. This stock has seen a small pullback in price but this just means I have an opportunity to pick up more shares at a discount. When you’re just starting out in building an investment portfolio, dollar cost averaging is the best way to go.

That’s what I’ve done with SBUX.

I purchased 18 shares of Starbucks Corporation (SBUX) on 4/26/2016 for $57.62 per share.

Valuation

• The P/E ratio is currently 33.3. This is slightly higher than the industry average of 28.7 and much higher than the S&P 500 average of 19.1.
• Morningstar valuation: $60, rated a 4 star “BUY”
• S&P Capital IQ valuation: $46.40, rated a 4 star “BUY”

Conclusion

Starbucks Corporation remains an attractive company for me to continue to invest in. Back in November 2015, when I first initiated a position in this company, I believed the company to be financially sound. So when given the opportunity to pick up more shares at a cheaper price, I jumped at the opportunity. I think there is still some potential for another small pullback for SBUX in the short-term but I remain confident in their long-term growth.

This additional purchase of SBUX adds an additional $14.40 to my annual dividend income, based on the current $0.20 quarterly dividend.

Full Disclosure: Long SBUX

Thanks for reading.

Images: Death to the Stock Photo with graphics added by One Woman’s Worth. 

Recent Buy // DIS

Let me preface this post by saying this- what a tumultuous beginning we’ve had in 2016! Investors were fearful for many reasons-including concerns over depressed oil prices and China’s lagging economy. But if you were one of the few people who wasn’t afraid and kept putting in money while others were pulling money out, you would likely be patting yourself on the back right now as you are reading this. Because you would know that the Dow and S&P500 are both up over 9% from the lows they hit in early February.

So while many were selling, I scooped up shares in a company that’s been on my watch list for a while; I purchased 12 shares of The Walt Disney Company (DIS) on 2/24/2016 for $93.41 per share.

Overview

The Walt Disney Company, more commonly known as Disney, is a well diversified multinational mass media and entertainment conglomerate. Founded on October 16, 1923 by Walt Disney and Rodney O. Disney as the Disney Brothers Cartoon Studio, the company soon established itself as a leader in the American animation industry. It has since diversified into the live-action film production, theme parks and television.

DIS operates in five segments (% of company revenue): Media Networks (43%) includes cable networks such as ESPN, Disney channel, Freeform and ABC; Parks (31%) which includes Disney World and Disney Land resorts, Spa Vacation Clubs, and Cruise lines; Studio Entertainment (15%) which includes all of the various franchises like Marvel Entertainment and Pixar; Consumer Products (8%) which includes the licensing and franchising of iconic logos and images owned by The Walt Disney Company; and Interactive (3%) which oversees various websites and interactive media owned by The Walt Disney Company and it’s subsidiaries.

Since The Walt Disney Company is so well diversified, they make their money in a multitude of ways. A few examples include advertising/sponsorships on media networks and interactive segments, ticket sales at theme parks and studio entertainment, licensing fees, and the sale of consumer products. Disney also does a wonderful job of integrating segments so that consumers of one segment are encouraged to purchase from other segments.

Quantitative

I know I’ve stated this at least twice already but let me say it again; The Walt Disney Company is extremely well diversified. That’s one of the things that really makes me keep a company under serious consideration- knowing that one part of the company could falter but understanding that there are other segments that can pick up the slack and keep the revenue machine going. Also the low debt on the balance sheet lets me know that DIS is primed for good financial health in the future.

• Revenue grew by approximately 5.66% over the last 5 years.
• EPS is 4.95 and has increased by 19.3% over the last 5 years.
• Dividend yield at time of purchase was 1.52% and DIS pays a dividend of $1.42 per share. DIS has been increasing dividends for 6 years and the payout ratio is currently 26.5%. This tells me there is still plenty of room for the dividend to grow at a healthy rate.
• Debt/Equity ratio: 0.29

Risks

The biggest risk that all anyone seems to talk about these days is cable “cord cutters” and the loss of subscriber fees. While ESPN and other popular channels make up a large percentage of  the media networks segment revenue (and DIS overall revenue), the company is well diversified in other areas to make up for the potential loss of revenue from that segment. I also believe that just because people are cutting their cable subscriptions that it doesn’t mean they aren’t watching these programs; consumers are just using other resources (going online, using apps, etc.) to watch these programs so there is an opportunity for DIS to make changes and redirect consumers to platforms where they can charge them directly for these programs (like HBO has done with HBO GO).

Valuation

• The P/E ratio at time of purchase was 17.8, which is lower than DIS’s 5 year average of 19.3.
• Morningstar valuation: $134, rated a 4 star “BUY”
• S&P Capital IQ valuation: $101, rated a 4 star “BUY”

Conclusion

The Walt Disney Company overall is an attractively valued high-quality stock. My hope is to continue adding to this position and let DIS serve as an anchor for my portfolio. They have a business model that is easy to understand, are well-respected as leaders in their industry, have a great balance sheet and have plenty of room to grow the dividend rate. Another clear winner, in my book!

This purchase adds $17.04 to my annual dividend income based on the current $0.71 semi-annual dividend.

Full Disclosure: Long DIS

Thanks for reading.

Images: Death to the Stock Photo with graphics added by One Woman’s Worth.

Recent Buy // TROW

Remember when I essentially said; “if it ain’t broke, don’t fix it” in November when I added to my position in Johnson & Johnson? Well, I really meant it. While there were many, many stocks on “sale” due to a horrible January, I decided to stick to what I knew- T.Rowe Price Inc.

In a market where many people are foregoing mutual funds and focusing on ETFs, TROW managed to still post excellent results in their latest quarterly earnings report. I already wrote on the merits of TROW back in September so I won’t bore you with repeated information.

I purchased 15 shares of T. Rowe Price Group Inc. (TROW) on 1/28/2016 for $68.69 per share.

Valuation

• The P/E ratio is currently 15.1 which is slightly below it’s 5 yr average. In addition, TROW P/E is currently below the broader market.
• S&P Capital IQ Valuation: $80.90

Conclusion

T. Rowe Price Group Inc. overall is an attractively valued high-quality stock, I think. They have a business model that is easy to understand, are well-respected as leaders in their industry, have a clean balance sheet and have plenty of room to grow the dividend rate. Again, a clear winner in my book!

This purchase adds $31.20 to my annual dividend income based on the current $0.52 quarterly dividend.

Full Disclosure: Long TROW

Thanks for reading.

Images: Death to the Stock Photo with graphics added by One Woman’s Worth.